Description
Cancer Nanotheranostics, 1st ed. 2021
Volume 2
Nanotechnology in the Life Sciences Series
Coordinators: Saravanan Muthupandian, Barabadi Hamed
Language: English
Subjects for Cancer Nanotheranostics:
Cancer Nanotheranostics
Publication date: 10-2022
368 p. · 15.5x23.5 cm · Paperback
Publication date: 10-2022
368 p. · 15.5x23.5 cm · Paperback
Cancer Nanotheranostics
Publication date: 10-2021
368 p. · 15.5x23.5 cm · Hardback
Publication date: 10-2021
368 p. · 15.5x23.5 cm · Hardback
Description
/li>Contents
/li>Biography
/li>Comment
/li>
Cancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows.
In the first volume of Cancer Nanotheranostics, we discuss the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies.
This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics.
Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research.
Preface
Chapter 1: Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Cancer
Dr. Rekha Pachaiappan, India
Chapter 2: Multifunctional Nanoparticles for Targeting Cancer Nanotheranostics
Dr. Ravichandran Manisekaran, Mexico
Chapter 3: Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives
Dr. Sanjeeb Sahoo, India
Chapter 4: Cancer-Targeted Nanotheranostics: Recent Advances and Future Perspectives
Dr. Maria Gazouli, Greece
Chapter 5: Nanotheranostics: A Future Remedy of Neurological Disorders
Dr. Saba Sohail, Pakistan
Chapter 6: Cancer Nano-Immunotherapy: Recent Advances and New Opportunites
Dr. Kamaraj Sathish-Kumar, Mexico
Chapter 7: Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics
Dr. Praveen T. Krishnamurthy, India
Chapter 8: Nanoparticle for Photoresponsive Minimal-Invasive Cancer Therapy
Dr. Shazid Md. Sharker, Bangladesh
Chapter 9: Biologically Synthesized Plant-Derived Nanomedicines and their In-Vitro In-Vivo Toxicity Studies in Various Cancer Therapeutics: Regulatory Perspectives
Dr. B. Balamuralikrishnan, Korea
Chapter 10: Nanoerythrosome: Biohybrid Microswimmers for Cancer Theranostics Cargo Delivery
Dr. Subbaraju Sree Gayathri, India
Chapter 11: Role of Artificial Intelligence in Cancer Nanotheranostics
Dr. Chockaiyan Usha, IndiaChapter 12: Limitations of Current Cancer Nanotheranositcs
Dr. Sujata Sawarkar, India
Chapter 13; Safety of nanobiomaterials for Cancer Nanotheranostics
Dr. Sujata Sawarkar, India
Index
Muthupandian Saravanan Graduated in Microbiology from Madurai Kamaraj University, India and Doctorate with Specialization in Medical Microbiology and Nanomedicine from Sathyabama University, India. Thereafter, He did a Post-Doctoral Research fellowship focusing his research on Nano-biomaterials & their Biomedical Applications (2011-2012). Prior to postdoc, he worked as an Assistant Professor (SG), SRM University, and Department of Biotechnology for six Years, from 2005 -2011. Presently, Dr. Saravanan working as a Professor, Department of Pharmacology Saveetha Dental college, SIMATS, Chennai, India and worked as Associate Professor, Department of Medical Microbiology and Immunology, Division of Bio-medical Sciences, School of Medicine, College of Health Science, Mekelle University, Ethiopia (2012-2021). His Research Specialization: Development of Novel biomaterials Emerging and Re-emerging Infectious disease and Cancer. He has published more than 150 research paper in Peer-reviewed Journal including high impact Journal with more than 8000 citations and h-index of 42 and i10 index of 85 and also three edited books. He has participated more than 75 National and International conferences, Reviewers of more than 100 international peer-reviewed journals and Guest editor/ Editors for various reputed PubMed and Scopus indexed journals. He has received many fellowships and awards notably, IET- Nanobiotechnology premium Awards two times continuously in the year 2019 and 2020, DST-SERC Young Scientist fellowship in 2011, International Fellowship “Advanced Course on Diagnostics” Sponsored by LSH&TM & Fondation Mérieux, in France 2013, International Fellowship “Pertussis: biology, epidemiology and prevention” meeting Sponsored by Fondation Mérieux & WHO in France 2014, International Union of Microbiological Societies (IUMS) travel grant in 2015 to Canada, International Fellowship "Advanced Course on Antibiotics” (AdCAb) Sponsored by Institute of Pasteur and Fondati
Broadens reader understanding of the role of nanomedicine as an alternative treatment strategy for cancer theranostics
Illustrates the cross-disciplinary nature of cancer nanotheranostics
Enriches understanding of how nanomaterials can be used as effective carriers to target cancer cells
© 2024 LAVOISIER S.A.S.
